| 摘要 |
<p>The present invention relates to a method for screening agents which modulate the binding of CDC5L to PLRG1, or specified fragments thereof, and agents identified using such an assay. The present invention also provides small peptides capable of inhibiting pre-mRNA splicing. Such agents are candidates for use in the treatment of , for example, cancer, or fungal infections.</p> |
